Warfarin can continue through cardiac rhythm device implantation

28 July 2009 | by Amy Corderoy Print this article Comments Share this article
Anti-arrhythmia devices can be implemented safely in high thromboembolic risk patients without the interrupting warfarin therapy, a pilot study has found....

Want to read complete article? Please Sign in or Register.

Recent comments

Most viewed articles this week

Related sites